Re-evaluation of the role of STOX1 transcription factor in placental development and preeclampsia

Journal of Reproductive Immunology

Volumn 82, Issue 2, 2009, Pages 174-181

  Rigourd, Virginie ^a,b,c   Chelbi, Sonia ^a,b   Chauvet, Caroline ^b,d   Rebourcet, Régis ^a,b   Barbaux, Sandrine ^a,b   Bessières, Bettina ^c   Mondon, Françoise ^a,b   Mignot, Thérèse Marie ^a,b   Danan, Jean Louis ^d   Vaiman, Daniel ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c Institut de Puericulture   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Gene expression profiling; Genetics; Preeclampsia; STOX1

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; TRANSCRIPTION FACTOR GCM1; TRANSCRIPTION FACTOR STOX1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 395; CARRIER PROTEIN; STOX1 PROTEIN, HUMAN;

CELLULAR DISTRIBUTION; CHROMOSOME 13Q; CHROMOSOME 5Q; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; INFLAMMATION; NONHUMAN; PATHOGENESIS; PLACENTA DEVELOPMENT; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; TRANSCRIPTION REGULATION; TROPHOBLAST; CHEMISTRY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PREGNANCY; PROTEIN TRANSPORT; REPRODUCTION;

CARRIER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PLACENTATION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PROTEIN TRANSPORT; TRANSCRIPTION, GENETIC;

EID: 77953390015     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.05.001     Document Type: Review

References (34)

1. Arngrimsson R., Bjornsson S., Geirsson R.T., Bjornsson H., Walker J.J., and Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br. J. Obstet. Gynaecol. 97 (1990) 762-769
2. Arngrimsson R., Sigurard ttir S., Frigge M.L., Bjarnad ttir R.I., Jonsson T., Stefansson H., Baldursdottir A., Einarsdottir A.S., Palsson B., Snorradottir S., Lachmeijer A.M., Nicolae D., Kong A., Bragason B.T., Gulcher J.R., Geirsson R.T., and Stefansson K. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum. Mol. Genet. 8 (1999) 1799-1805
3. Anson-Cartwright L., Dawson K., Holmyard D., Fisher S.J., Lazzarini R.A., and Cross J.C. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25 (2000) 311-314
4. Batista F., Vaiman D., Dausset J., Fellous M., and Veitia R.A. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 3330-3335
5. Berends A.L., Bertoli-Avella A.M., de Groot C.J., van Duijn C.M., Oostra B.A., and Steegers E.A. STOX1 gene in pre-eclampsia and intrauterine growth restriction. Bjog 114 (2007) 1163-1167
6. Buffat C., Mondon F., Rigourd V., Boubred F., Bessieres B., Fayol L., Feuerstein J.M., Gamerre M., Jammes H., Rebourcet R., Miralles F., Courbieres B., Basire A., Dignat-Georges F., Carbonne B., Simeoni U., and Vaiman D. A hierarchical analysis of transcriptome alterations in intrauterine growth restriction (IUGR) reveals common pathophysiological pathways in mammals. J. Pathol. 213 (2007) 337-346
7. Chelbi S.T., Mondon F., Jammes H., Buffat C., Mignot T.M., Tost J., Busato F., Gut I., Rebourcet R., Laissue P., Tsatsaris V., Goffinet F., Rigourd V., Carbonne B., Ferre F., and Vaiman D. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 49 (2007) 76-83
8. Chen C.P., Chen C.Y., Yang Y.C., Su T.H., and Chen H. Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia. Placenta 25 (2004) 413-421
9. Chim S.S., Tong Y.K., Chiu R.W., Lau T.K., Leung T.N., Chan L.Y., Oudejans C.B., Ding C., and Lo Y.M. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 14753-14758
10. Cnattingius S., Reilly M., Pawitan Y., and Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am. J. Med. Genet. A 130 (2004) 365-371
11. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 (2003) P3
12. Esplin M.S., Fausett M.B., Fraser A., Kerber R., Mineau G., Carrillo J., and Varner M.W. Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med. 344 (2001) 867-872
13. Fitzpatrick E., Goring H.H., Liu H., Borg A., Forrest S., Cooper D.W., Brennecke S.P., and Moses E.K. Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2. Hum. Biol. 76 (2004) 849-862
14. Founds S.A., Conley Y.P., Lyons-Weiler J.F., Jeyabalan A., Allen Hogge W., and Conrad K.P. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 30 (2009) 15-24
15. Graves J.A. Genomic imprinting, development and disease-is pre-eclampsia caused by a maternally imprinted gene?. Reprod. Fertil. Dev. 10 (1998) 23-29
16. Iglesias-Platas I., Monk D., Jebbink J., Buimer M., Boer K., van der Post J., Hills F., Apostolidou S., Ris-Stalpers C., Stanier P., and Moore G.E. STOX1 is not imprinted and is not likely to be involved in preeclampsia. Nat. Genet. 39 (2007) 279-280
17. Johnson M.P., Fitzpatrick E., Dyer T.D., Jowett J.B., Brennecke S.P., Blangero J., and Moses E.K. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol. Hum. Reprod. 13 (2007) 61-67
18. Kanayama N., Takahashi K., Matsuura T., Sugimura M., Kobayashi T., Moniwa N., Tomita M., and Nakayama K. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol. Hum. Reprod. 8 (2002) 1129-1135
19. Kangaspeska S., Stride B., Metivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., Benes V., Gannon F., and Reid G. Transient cyclical methylation of promoter DNA. Nature 452 (2008) 112-115
20. Kivinen K., Peterson H., Hiltunen L., Laivuori H., Heino S., Tiala I., Knuutila S., Rasi V., and Kere J. Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur. J. Hum. Genet. 15 (2007) 494-497
21. Laasanen J., Hiltunen M., Romppanen E.L., Punnonen K., Mannermaa A., and Heinonen S. Microsatellite marker association at chromosome region 2p13 in Finnish patients with preeclampsia and obstetric cholestasis suggests a common risk locus. Eur. J. Hum. Genet. 11 (2003) 232-236
22. Lachmeijer A.M., Arngrimsson R., Bastiaans E.J., Frigge M.L., Pals G., Sigurdardottir S., Stefansson H., Palsson B., Nicolae D., Kong A., Aarnoudse J.G., Gulcher J.R., Dekker G.A., ten Kate L.P., and Stefansson K. A genome-wide scan for preeclampsia in the Netherlands. Eur. J. Hum. Genet. 9 (2001) 758-764
23. Moses E.K., Fitzpatrick E., Freed K.A., Dyer T.D., Forrest S., Elliott K., Johnson M.P., Blangero J., and Brennecke S.P. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol. Hum. Reprod. 12 (2006) 505-512
24. Moses E.K., Lade J.A., Guo G., Wilton A.N., Grehan M., Freed K., Borg A., Terwilliger J.D., North R., Cooper D.W., and Brennecke S.P. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am. J. Hum. Genet. 67 (2000) 1581-1585
25. Nishizawa H., Pryor-Koishi K., Kato T., Kowa H., Kurahashi H., and Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 28 (2007) 487-497
26. Rigourd V., Chauvet C., Chelbi S.T., Rebourcet R., Mondon F., Letourneur F., Mignot T.M., Barbaux S., and Vaiman D. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS One 3 (2008) e3905
27. Sibai B.M. Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies?. Hypertension 46 (2005) 1252-1253
28. Sichtig N., Silling S., and Steger G. Papillomavirus binding factor (PBF)-mediated inhibition of cell growth is regulated by 14-3-3beta. Arch. Biochem. Biophys. 464 (2007) 90-99
29. van Dijk M., Mulders J., Poutsma A., Konst A.A., Lachmeijer A.M., Dekker G.A., Blankenstein M.A., and Oudejans C.B. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat. Genet. 37 (2005) 514-519
30. Winn V.D., Haimov-Kochman R., Paquet A.C., Yang Y.J., Madhusudhan M.S., Gormley M., Feng K.T., Bernlohr D.A., McDonagh S., Pereira L., Sali A., and Fisher S.J. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology 148 (2007) 1059-1079
31. Yang C.S., Yu C., Chuang H.C., Chang C.W., Chang G.D., Yao T.P., and Chen H. FBW2 targets GCMa to the ubiquitin-proteasome degradation system. J. Biol. Chem. 280 (2005) 10083-10090
32. Yu C., Shen K., Lin M., Chen P., Lin C., Chang G.D., and Chen H. GCMa regulates the syncytin-mediated trophoblastic fusion. J. Biol. Chem. 277 (2002) 50062-50068
33. Zhou C.C., Zhang Y., Irani R.A., Zhang H., Mi T., Popek E.J., Hicks M.J., Ramin S.M., Kellems R.E., and Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 14 (2008) 855-862
34. Zintzaras E., Kitsios G., Harrison G.A., Laivuori H., Kivinen K., Kere J., Messinis I., Stefanidis I., and Ioannidis J.P. Heterogeneity-based genome search meta-analysis for preeclampsia. Hum. Genet. 120 (2006) 360-370